SCN9A rs121918666: What Your Genotype Means
The rs121918666 variant is a specific alteration within the SCN9A gene, which provides instructions for building sodium channels in nerve cells. This variant is associated with autosomal dominant painful channelopathies, including primary erythromelalgia, a condition characterized by intense burning pain and redness in the extremities.
What each genotype means
Typical sodium channel function
This genotype represents the most common genetic sequence found in the general population for this location in the SCN9A gene. It is not associated with the rare, inherited painful channelopathies like primary erythromelalgia or paroxysmal extreme pain disorder. No specific clinical action is indicated based on this result.
This is the most common genotype observed across all global populations.
Potential variant carrier
This genotype indicates the presence of one copy of the variant. While some SCN9A variants are linked to autosomal dominant pain disorders, the clinical significance of this specific variant is complex and may be influenced by other genetic or environmental factors. You should discuss these findings with a genetic counselor or your healthcare provider to understand if this result is relevant to your personal health history.
This genotype is rare, occurring in a very small percentage of the population.
Rare variant carrier
This genotype indicates the presence of two copies of the variant. Because this variant is associated with autosomal dominant painful channelopathies, individuals with this result may have an increased susceptibility to conditions like primary erythromelalgia or small fiber neuropathy. Please consult with a medical professional to interpret these results in the context of your symptoms and family history.
This genotype is extremely rare in the general population.
Understanding the SCN9A Gene
The SCN9A gene encodes the Nav1.7 voltage-gated sodium channel, a protein that acts as a gatekeeper for sodium ions entering nerve cells. These channels are highly concentrated in nociceptors, which are specialized sensory neurons responsible for detecting pain. By controlling the flow of sodium ions, Nav1.7 channels help regulate the electrical excitability of these neurons, effectively setting the threshold for when a pain signal is sent to the brain. When the SCN9A gene functions normally, it ensures that pain signals are transmitted appropriately in response to stimuli. However, certain variants can alter the structure or function of these channels, potentially leading to hyperexcitability where neurons fire too easily or too frequently, resulting in chronic or episodic pain syndromes.
The Role of rs121918666 in Pain Syndromes
The rs121918666 variant is categorized as a gain-of-function mutation. In the context of SCN9A, gain-of-function means the sodium channel remains open longer than it should or opens too easily, causing an influx of sodium that makes the nerve cell hyper-responsive. Research associates this specific variant with primary erythromelalgia, a rare condition where patients experience intermittent, severe burning pain, warmth, and redness in the hands and feet, often triggered by heat. While the evidence linking specific SCN9A variants to these painful channelopathies is considered moderate to strong in clinical literature, it is important to note that not all individuals with a variant will experience the same severity of symptoms. Recent studies have also suggested that some variants previously labeled as pathogenic may have variable penetrance, meaning the clinical expression can differ significantly between individuals.
Population Frequency and Clinical Context
The rs121918666 variant is considered rare in the general population. Because it is associated with a specific, rare clinical phenotype, it is not typically found in large-scale, healthy population databases at high frequencies. Most individuals do not carry this variant. When it is identified, it is often in the context of clinical diagnostic testing for patients presenting with unexplained, severe neuropathic pain. It is crucial to understand that the presence of a rare variant does not automatically confirm a diagnosis of a specific syndrome. Clinical diagnosis relies on a combination of physical examination, patient history, and functional testing. If you have received results indicating the presence of this variant, it is essential to discuss the findings with a medical geneticist or a neurologist who specializes in pain disorders to understand the clinical implications for your specific health profile.
Navigating Genetic Information
Genetic information regarding variants like rs121918666 should be interpreted with caution. While scientific research has established a link between SCN9A mutations and pain disorders, the field is rapidly evolving. Some recent studies have indicated that a portion of variants previously thought to be strictly pathogenic may not always result in clinical pain symptoms, suggesting that other genetic or environmental factors may play a role. You cannot use this information to self-diagnose or predict future health outcomes without professional guidance. If you are experiencing symptoms such as chronic pain, burning sensations, or sensitivity to temperature, consult a healthcare provider. Furthermore, if you are considering medication based on genetic findings, always discuss dosing and treatment strategies with your clinician or pharmacist, as they can provide personalized advice based on your full medical history and current clinical status.
How common is this variant?
The rs121918666 variant is rare across all global populations, appearing only sporadically in clinical cohorts rather than as a common polymorphism.
Frequently asked questions
What is the SCN9A gene?
The SCN9A gene provides instructions for making a sodium channel called Nav1.7, which is essential for transmitting pain signals in the nervous system.
Is rs121918666 a cause of erythromelalgia?
Research has associated this variant with primary erythromelalgia, a condition causing burning pain and redness in the extremities. However, clinical diagnosis requires a professional evaluation.
What should I do if I have this variant?
If you have this variant, you should consult with a medical geneticist or a neurologist. They can help interpret the results in the context of your personal health and symptoms.
Are all SCN9A variants harmful?
Not all variants in the SCN9A gene are harmful. Recent research suggests that some variants previously thought to be pathogenic may have variable effects on pain sensitivity.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918666?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SCN9A
This voltage-gated sodium channel variant modulates nociceptive sensitivity, causing carriers to exhibit higher pain thresholds across various sensory modalities.
Variants in SCN9A are linked to autosomal dominant painful channelopathies, including primary erythromelalgia and paroxysmal extreme pain disorder.
A pathogenic variant in SCN9A linked to paroxysmal extreme pain disorder, relevant for carrier screening in hereditary pain syndromes.